Sponsor:
ViiV Healthcare
Code:
NCT07650916
Conditions
HIV Infections
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
CAB ULA
RPV ULA
CAB LA
RPV LA
Brief summary:
Conditions
HIV Infections
Study ID
NCT07650916
Start date
Jun 25, 2026
Status verified date
Aug, 2026
Completion date
Sep 4, 2029
Anticipated
Primary completion date
Sep 4, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Enrollment
564 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: CAB ULA+ RPV ULA
active comparator: CAB LA+ RPV LA
Interventions
CAB ULA
RPV ULA
CAB LA
RPV LA
Primary outcome measure
Central contacts
Locations
GSK Investigational Site
Recruiting
Phoenix, Arizona, United States, 85015
Contacts
Principal Investigator:
Douglas Cunningham
GSK Investigational Site
Recruiting
Bakersfield, California, United States, 93301
Contacts
Principal Investigator:
Franco Felizarta
GSK Investigational Site
Recruiting
Los Angeles, California, United States, 90027
Contacts
Principal Investigator:
William Towner
GSK Investigational Site
Recruiting
Los Angeles, California, United States, 90036
Contacts
Principal Investigator:
Peter Ruane
GSK Investigational Site
Recruiting
San Diego, California, United States, 92103
Contacts
Principal Investigator:
Timothy Wilkin
GSK Investigational Site
Recruiting
New Haven, Connecticut, United States, 06510
Contacts
Principal Investigator:
Onyema Ogbuagu
GSK Investigational Site
Recruiting
Washington D.C., District of Columbia, United States, 20017
Contacts
Principal Investigator:
Theo Hodge
GSK Investigational Site
Recruiting
DeLand, Florida, United States, 32720
Contacts
Principal Investigator:
Godson Oguchi
GSK Investigational Site
Recruiting
Fort Lauderdale, Florida, United States, 33316
Contacts
Principal Investigator:
Michael Sension
GSK Investigational Site
Recruiting
Ft. Pierce, Florida, United States, 34982
Contacts
Principal Investigator:
Moti Ramgopal
GSK Investigational Site
Recruiting
Miami, Florida, United States, 33136
Contacts
Principal Investigator:
Charles Mitchell
GSK Investigational Site
Recruiting
Orlando, Florida, United States, 32803
Contacts
Principal Investigator:
Charlotte-Paige Rolle
GSK Investigational Site
Recruiting
Pensacola, Florida, United States, 32503
Contacts
Principal Investigator:
Mitchell Whitehead
GSK Investigational Site
Recruiting
Vero Beach, Florida, United States, 32960
Contacts
Principal Investigator:
Gerald Pierone
GSK Investigational Site
Recruiting
West Palm Beach, Florida, United States, 33407
Contacts
Principal Investigator:
Olayemi Osiyemi
GSK Investigational Site
Recruiting
West Palm Beach, Florida, United States, 33409
Contacts
Principal Investigator:
Hector Bolivar
GSK Investigational Site
Recruiting
Decatur, Georgia, United States, 30033
Contacts
Principal Investigator:
Alexandra Dretler
GSK Investigational Site
Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contacts
Principal Investigator:
Leonard Johnson
GSK Investigational Site
Recruiting
Kansas City, Missouri, United States, 64111
Contacts
Principal Investigator:
Blair Thedinger
GSK Investigational Site
Recruiting
Las Vegas, Nevada, United States, 89101
Contacts
Principal Investigator:
Jerry Cade
GSK Investigational Site
Recruiting
Newark, New Jersey, United States, 07102
Contacts
Principal Investigator:
Jihad Slim
GSK Investigational Site
Recruiting
Santa Fe, New Mexico, United States, 87505
Contacts
Principal Investigator:
Joel Gallant
GSK Investigational Site
Recruiting
Stony Brook, New York, United States, 11794
Contacts
Principal Investigator:
Sharon Nachman
GSK Investigational Site
Recruiting
Syracuse, New York, United States, 13057
Contacts
Principal Investigator:
Elizabeth Asiago-Reddy
GSK Investigational Site
Recruiting
Greensboro, North Carolina, United States, 27401
Contacts
Principal Investigator:
Cornelius Van Dam
GSK Investigational Site
Recruiting
Columbus, Ohio, United States, 43210
Contacts
Principal Investigator:
Jose Bazan
GSK Investigational Site
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Principal Investigator:
William Short
GSK Investigational Site
Recruiting
Austin, Texas, United States, 78705
Contacts
Principal Investigator:
Cynthia Brinson
GSK Investigational Site
Recruiting
Dallas, Texas, United States, 75219
Contacts
Principal Investigator:
Marc Tribble
GSK Investigational Site
Recruiting
Dallas, Texas, United States, 75246
Contacts
Principal Investigator:
Christopher Bettacchi
GSK Investigational Site
Recruiting
El Paso, Texas, United States, 79902
Contacts
Principal Investigator:
Ogechika Alozie
GSK Investigational Site
Recruiting
Houston, Texas, United States, 77098
Contacts
Principal Investigator:
Gordon Crofoot, Jr., MD
GSK Investigational Site
Recruiting
Salt Lake City, Utah, United States, 84102
Contacts
Principal Investigator:
Harry Rosado-Santos
GSK Investigational Site
Recruiting
Lynchburg, Virginia, United States, 24501
Contacts
Principal Investigator:
Joseph Saabiye
GSK Investigational Site
Recruiting
Seattle, Washington, United States, 98104
Contacts
Principal Investigator:
Peter Shalit
GSK Investigational Site
Recruiting
Vancouver, British Columbia, Canada, V6Z 2T1
Contacts
Principal Investigator:
Malcolm Hedgcock
GSK Investigational Site
Recruiting
Toronto, Ontario, Canada, M5G 1K2
Contacts
Principal Investigator:
Mona Loutfy
GSK Investigational Site
Recruiting
Montreal, Quebec, Canada, H2L 4E9
Contacts
Principal Investigator:
Elise Sasseville
GSK Investigational Site
Recruiting
Montreal, Quebec, Canada, H2L 4P9
Contacts
Principal Investigator:
Jason Szabo
Sponsor
ViiV Healthcare
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-07. This information was provided to ClinicalTrials.gov by ViiV Healthcare on 2026-08-14.